The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation

Warfarin is used as anticoagulant and Compound Danshen prescription (CDP) is able to promote blood circulation. The combination might produce a synergic effect for patients of coronary heart diseases (CHDs) with atrial fibrillation (AF). Whether the combination increases the bleeding risk of warfari...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Pharmacol
Glavni autori: Lv, Chunxiao, Liu, Changxiao, Yao, Zhuhua, Gao, Xiumei, Sun, Lanjun, Liu, Jia, Song, Haibo, Li, Ziqiang, Du, Xi, Sun, Jinxia, Li, Yanfen, Ye, Kui, Wang, Ruihua, Huang, Yuhong
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2017
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5702344/
https://ncbi.nlm.nih.gov/pubmed/29209208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00826
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items